Heranba IPO opens today: Key things to know before you subscribe Over the past three years, Heranba's revenue grew at a CAGR of 13.3 per cent to Rs 951 crore in FY20 while its EBITDA and net profits grew at much faster pace of 21.4 per cent and 44.4 per cent, respectively, during the period Niti Kiran | February 23, 2021 | Updated 12:48 IST The company has priced its issue at a PE of 25x which is at a discount to the peers-- its peers such as Rallis India, Sumitomo Chemicals and Bharat Rasayan are trading at a trailing PE of 23.1, 47.3 and 27.0, respectively The seventh public offer of this month, that of Heranba Industries, has hit Dalal Street today. This Gujarat-based crop protection chemical manufacturer, exporter, and marketing company is one of the leading domestic producers of synthetic pyrethroids with a 20 per cent market share, and has presence in a wide range of products across the entire value chain of synthetic pyrethroids. It has an extensive 9,400 dealers or distributors supported by 21 stock depots spread across 16 states and 1 union territory in India.